Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 1741 of 3054 -
Thursday, April 02 2026 | 06:31:35 AM

CFO Resigns

Interim CFO Appointed Vancouver, British Columbia–(Newsfile Corp. – April 30, 2025) – Mark Jarvis, CEO of Shoal Point Energy Ltd. (CSE: SHP) (“The Company”), announced today that the Board of the Company has accepted the resignation of Natasha Tsai as Chief Financial Officer of the Company, effective at today’s date. …

Read More »

Central Puerto Announces Reporting Date for the First Quarter 2025 Financial Results Conference Call and Webcast

Buenos Aires, Argentina–(Newsfile Corp. – April 30, 2025) – Central Puerto S.A (NYSE: CEPU) (“Central Puerto” or the “Company”) one of the largest private sector power generation companies in Argentina, will issue a press release announcing its First Quarter results on May 12, 2025. Mr. Fernando Bonnet, Chief Executive Officer, …

Read More »

Centaurus Energy Provides Update on 2024 Annual Financial Statement Filings

Calgary, Alberta–(Newsfile Corp. – April 30, 2025) – Centaurus Energy Inc. (TSXV: CTA) (OTC Pink: CTARF) (“Centaurus” or the “Company”) provides this default announcement indicating Centaurus’s anticipated failure to file its annual financial statements for the year ended December 31, 2024 and related management discussion and analysis and certifications (collectively, …

Read More »

Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets

Northvale, New Jersey–(Newsfile Corp. – April 30, 2025) – Elite Pharmaceuticals, Inc. (OTCQB: ELTP) (“Elite” or the “Company”), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite’s generic version of Percocet® (oxycodone hydrochloride and acetaminophen tablets, USP CII) 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets. Oxycodone …

Read More »

NuGen Announces Release of 2024 Annual Financial Results

Toronto, Ontario–(Newsfile Corp. – April 30, 2025) –  NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”) a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of 2024 Annual Financial Results. Annual Financial Statements Reflect Commercial Ramp Up The orders announced previously in …

Read More »